Women's Health & Breast Cancer Awareness Month 2004 Feature Releases.SAN FRANCISCO -- The following releases focus on the topic Women's Health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. & Breast Cancer Awareness Month: ALL TIME-OFFS ARE IN EASTERN TIME ST. HELENA, Calif.--'Think Pink' is the Message from Sutter Home in Its 'Capsules for the Cure' Program to Fight Breast Cancer (09/01/2004 - 11:43 AM, SOURCE: Sutter Home) ST. HELENA, Calif.--Website Items Will Have Consumers Looking and Riding ``Pretty in Pink'' While Supporting Programs to Fight Breast Cancer (09/07/2004 - 11:30 AM, SOURCE: Sutter Home Family Vineyards/Trinchero Family Estates) ST. PAUL, Minn.--Show That You're `Sticking Up' for Breast Cancer Research; Introducing Pink Ribbon Post-it Super Sticky Notes (09/08/2004 - 12:00 PM, SOURCE: 3M, NYSE NYSE See: New York Stock Exchange :MMM MMM Myeloid metaplasia with myelofibrosis, see there ) NEW YORK--Wacoal Introduces New Programs to Aid in the Fight Against Breast Cancer; New Programs Raise Awareness & Generate Additional Funding for the Susan G. Komen Breast Cancer Foundation (09/08/2004 - 12:30 PM, SOURCE: Wacoal) ANAHEIM, Calif.--Mobile Edge Joins Fight Against Breast Cancer; Innovative Laptop Case Designer Launches ``The Caring Case'' Collection to Benefit the Susan G. Komen Breast Cancer Foundation (09/08/2004 - 12:30 PM, SOURCE: Mobile Edge) AVAILABLE EXPERTS The following knowledgeable industry leaders and scholars from Business Wire's ExpertSource database are available to discuss topics relating to Women's Health & Breast Cancer Awareness Month: --From weight gain, sex drive to hormone replacement therapy Hormone Replacement Therapy Definition Hormone replacement therapy (HRT) is the use of synthetic or natural female hormones to make up for the decline or lack of natural hormones produced in a woman's body. and its alternatives, Rebecca Hulem offers an informed and humorous discussion about menopause and perimenopause perimenopause /peri·meno·pause/ (-men´o-pawz) the time just before and after menopause.perimenopau´sal per·i·men·o·pause n. . Rebecca is an author and acclaimed international speaker who lends more than 25 years of experience as a woman's health practitioner (registered nurse/midwife). Along the way, Rebecca has personally delivered more than 2,000 babies! In 2003, Rebecca left the corporate world to start her own business as a dynamic speaker and author on the subject of menopause. She has traveled internationally speaking professionally to women of all ages on how to stay healthy and sane in spite of their hormones. With a reputation as a caring, nurturing and informed woman who is truly passionate about helping other women find answers to their health issues, Ms. Hulem has truly connected with her core audience. Now widely known as "The Menopause Expert" (http://themenopauseexpert.com), Rebecca has been interviewed by numerous media outlets regarding the much talked about controversy on hormone replacement therapy for women in menopause. Rebecca Hulem offers teleclasses and workshops to women worldwide and continuing education units to the medical community. Her debut book, Feelin' Hot?, offers a humorous, informative and truthful look at menopause. Her follow-up publication, Conversations on Health and Wellness, was co-authored with Dr. John Gray (best-selling author of Men Are From Mars, Women Are From Venus). Available in bookstores and at Amazon.com, Rebecca also co-authored Changing Course: Women's Inspiring Stories on Midlife, Menopause and Moving Forward, which features a motivational essay about Hulem's difficult early life and how she overcame many life challenges to get where she is today. Rebecca can discuss hormone replacement therapy and alternatives to reduce breast cancer risks. 818-889-2475, rebecca@themenopauseexpert.com, PR Contact: Rebecca Mettler, 949-643-6765 or 866-687-6886 ext. 1, rebeccapr@sbcglobal.net --Dr. John S. Link is an internist and oncologist who has been an active member of the Long Beach Memorial medical staff since 1977, serving as Department of Medicine Chair 1989-1990. He is the founding Medical Director of two Memorial Care Breast Centers, one at the Memorial Hospital (ranked by Self magazine as one of America's ten best breast centers) in Long Beach, Calif., and one at Orange Coast Memorial Hospital in Fountain Valley. He is also the Medical Director of the Pacific Coast Breast Center in Torrance. Dr. Link is board certified by the American Board of Internal Medicine The American Board of Internal Medicine (ABIM) is a non-profit, independent physician organization in the U.S. that certifies physicians who practice in internal medicine and its sub-specialties. and the American Board of Oncology, and is a member of the American Society of Breast Disease and American College of Physicians The American College of Physicians (ACP) is a national organization of doctors of internal medicine (internists), physicians who specialize in the prevention, detection and treatment of illnesses in adults. . Dr. Link is a clinical assistant professor of Medicine at the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). Irvine, College of Medicine and is an international lecturer/teacher and researcher. He has presented over 40 major courses on breast cancer management since 1988. He is the principal research investigator for the National Cancer Institute approved National Surgical Adjuvant Breast Project National Surgical Adjuvant Breast Project See NSABP. (NSABP NSABP National Surgical Adjuvant Breast Project Oncology A series of ongoing multicenter clinical trials evaluating the effects of various therapies, including RT, surgery and chemotherapy–eg, tamoxifen and 5-FU, in treating advanced breast or colorectal CAs ) and NSABP Breast Cancer Prevention Trial and is co-investigator for the Southwest Oncology Group The Southwest Oncology Group (SWOG) is a National Cancer Institute (NCI) sponsored organization that conducts clinical trials in adult cancers. SWOG was created by the NCI in 1956, and its was headquartered in Houston, Texas. Project #15858. Dr. Link is dedicated to the advancement of breast cancer research. He believes that each woman's situation is as unique as she is, and her treatment plan should be based on compassion and excellence. PR Contact: Jim Goyjer, 310-207-0209, info@breastlink.org --Dr. Joyce O'Shaughnessy is currently a breast cancer researcher and practitioner at Texas Oncology, P.A. in Dallas and is Associate Director for clinical research for US Oncology. She is also Director, Chemoprevention che·mo·pre·ven·tion n. The use of chemical agents, drugs, or food supplements to prevent disease. chemoprevention Research and Co-Director, Breast Cancer Research for US Oncology. Dr. O'Shaughnessy's major area of research interest is the development of breast cancer, and she is involved in several ongoing chemoprevention studies. Dr. O'Shaughnessy did her internship and residence in internal medicine at Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world , followed by her fellowship in medical oncology at the National Cancer Institute (NCI See Liberate. ). She served as special assistant to the NCI director from 1988 to 1990 and coordinated the development of new cancer drug approval guidelines for the NCI and Food and Drug Administration. Dr. O'Shaughnessy then served as a Senior Investigator in the Medical Breast Cancer Section of the NCI from 1990 through 1995. In this role, she conducted many breast cancer treatment This article or section recently underwent a major revision or rewrite and needs further review. You can help! The mainstay of breast cancer treatment is surgery when the tumor is localized, with possible adjuvant hormonal therapy (with tamoxifen or an aromatase clinical trials, including evaluation of high-dose chemotherapies and hematopoietic hematopoietic /he·ma·to·poi·et·ic/ (-poi-et´ik) 1. pertaining to hematopoiesis. 2. an agent that promotes hematopoiesis. hematopoietic 1. pertaining to or affecting the formation of blood cells. growth factors, new cytotoxic drug combinations, novel hormonal treatments, monoclonal antibody and gene therapies for breast cancer. Dr. O'Shaughnessy also has served as principal investigator on several tissue-based breast cancer prevention clinical trials involving the administration of fenretinide, tamoxifen tamoxifen (təmŏk`sĭfĕn'), synthetic hormone used in the treatment of breast cancer. Introduced in 1978, tamoxifen is used to prevent recurrences of cancer in women who have already undergone surgery to remove their tumors. , and other SERMs to women at high risk for the development of breast cancer. Dr. O'Shaughnessy has been published and spoken widely on new prevention and treatment strategies for breast cancer. 214-370-1000, joyce.oshaughnessy@usoncology.com Registered journalists can submit queries to the ExpertSource staff and/or search for more experts in this and various other topics by going to http://www.businesswire.com and logging in with your email address and PressPass password. If you are not registered, you may do so at http://www.businesswire.com. For more information or assistance with ExpertSource, please contact Stacey Seigler, ExpertSource Coordinator/Business Wire at 312-223-1037, stacey.seigler@businesswire.com . The following are upcoming Features Package release dates: Sept. 15 - Fall Home & Garden Sept. 22 - Gift Guide I Sept. 29 - World Series Oct. 6- Halloween Questions? Contact Business Wire's Media Relations team at media.relations@businesswire.com |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion